Recommendations pertaining to the use of viral vaccines: influenza, 2005
Schoub, B.D.
South African Medical Journal 95(2): 104
2005
ISSN/ISBN: 0256-9574 PMID: 15751203 Document Number: 593556
Document emailed within 1 workday
Related Documents
Liehl, E.; Bachmayer, H. 1977: Viral antigens and impurities in influenza vaccines. Evaluation by immunoelectrophoretic methods Developments in Biological Standardization 39: 163-168Kustikova, I.G.; Gagarinova, V.M.; Gorev, N.E.; Shadrin, A.S. 1983: Immunogenic activity of the viral hemagglutinin and neuraminidase from live and inactivated influenza vaccines Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 4: 79-84
2000: Delayed supply of influenza vaccine and adjunct ACIP influenza vaccine recommendations for the 2000-01 influenza season. Advisory Committee on Immunization Practices Mmwr. Morbidity and Mortality Weekly Report 49(27): 619-622
Markushin, S.G.; Akopova, I.I.; Koptiaeva, I.B.; Tsfasman, T.M.; Gendon, I.Z. 2006: Molecular mechanisms of reversions to the ts+ -phenotype of cold-adapted influenza virus a strains--attenuation donors for live influenza reassortant vaccines Voprosy Virusologii 51(5): 17-22
Barinskiĭ, I.F.; Nesterchuk, S.L. 1995: Killed specific viral vaccines for therapeutic use in chronic viral infections Voprosy Virusologii 40(1): 5-8
Hottle, G. 1976: Vaccines. VI. Further advances in viral vaccines Gaceta Medica de Mexico 111(4): 279-284
Grado, C.; Contreras, G.; Suárez, M. 1977: I. Viral vaccines. Vaccines of common use Revista Chilena de Pediatria 48(2): 94-98
Higashihara, M.; Igarashi, Y.; Saito, Y. 1976: Recombinant influenza-virus vaccines. IV. Segregation of antigenic and some biological properties of Influenza virus neuraminidase by recombination Kitasato Archives of Experimental Medicine 49(3): 81-91
Bernstein, D.I.; Zahradnik, J.M.; DeAngelis, C.J.; Cherry, J.D. 1982: Influenza immunization in children and young adults: clinical reactions and total and IgM antibody responses after immunization with whole-virus or split-product influenza vaccines American Journal of Diseases of Children 136(6): 513-517
Sarateanu, D.E.; Ehrengut, W. 1981: Influenza vaccination. The importance of antigen amount and adjuvant with reference to the humoral antibody formation after influenza vaccination. A comparative double-blind study with various vaccines Fortschritte der Medizin 99(34): 1348-1352
Cassetti, M.Cristina.; Katz, J.M.; Wood, J. 2006: Report of a consultation on role of immunological assays to evaluate efficacy of influenza vaccines. Initiative for Vaccine Research and Global Influenza Programme, World Health Organization, Geneva, Switzerland, 25 January 2005 Vaccine 24(5): 541-543
Higashihara, M. 1975: Studies on genetic recombinants of influenza virus: fundamental studies on recombinant influenza-virus vaccines Kitasato Archives of Experimental Medicine 48(4): 183-188
Ghendon, Y. 1990: The immune response to influenza vaccines Acta Virologica 34(3): 295-304
Wright, P.F.; Karzon, D.T. 1987: Live attenuated influenza vaccines Progress in Medical Virology. Fortschritte der Medizinischen Virusforschung. Progres en Virologie Medicale 34: 70-88
Gendon, I.Z.; Vasiliev, I.M. 2011: Problem of influenza prophylaxis by vaccines Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 4: 115-124
Tripp, R.A.; Tompkins, S.M. 2008: Recombinant vaccines for influenza virus Current Opinion in Investigational Drugs 9(8): 836-845
Sato, K.; Itamura, S. 2010: Trends and perspectives in development of influenza vaccines Nihon Rinsho. Japanese Journal of Clinical Medicine 68(9): 1697-1701
McCarthy, M.A. 1982: Recommendations on influenza vaccine for 1982-83 Pennsylvania Medicine 85(11): 24
Gendon, I.Z.; Markushin, S.G.; Krivtsov, G.G.; Akopova, I.I. 2008: Chitosan as an adjuvant for parenteral inactivated influenza vaccines Voprosy Virusologii 53(5): 14-19
Gendon, I.Z. 2001: Live cold-adapted reassortant influenza vaccines Voprosy Virusologii 46(3): 5-12